Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.22.2.2
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Net loss attributable to the non-controlling interest     $ (2,307) $ (1,468)
BioCorRx Pharmaceuticals, Inc [Member]        
Net loss $ (7,257) $ (2,860) $ (9,533) $ (6,067)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20% 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (1,756) $ (692) $ (2,307) $ (1,468)